6.830
−0,15%
2026-10-19
Fundamental Analysis
7 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -436.9% | -476.9% | 1 / 3 | -42.9% | -4.19 pp | -11.99 pp | -13.7% | 1.97 | — | 113 | −42,9% | −11,6 | −436,9% | — | -9.08 | — |
| Pts | 0 | 0 | 4 | 0 | 0 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 6.830 (close price on 2026-10-19)EPS (TTM): −1.034,5
Financial charts
1.Revenue & growth
VND bn113Q2/26
1.Revenue & growth
VND bn113Q2/26
2.Profit & growth
VND bn-11,6Q2/26
3.Profit mix (Penman)
VND bn-14,3Q2/26
4.Margins & cost structure
%7.1%Q2/26
5.Returns & cash cycle
% · days-0.0%Q2/26
6.Earnings quality & cash
VND bn78,2Q2/26
7.Asset structure
VND bn302Q2/26
8.Funding & debt health
VND bn · times302Q2/26
9.Revenue backlog
VND bn0,37Q2/26
10.Valuation
times · %-8,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-763Q2/26
Adjusted EPS growth, latest quarter
-437%
Average adjusted EPS growth, 3 quarters
-755%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26